Sirio debuts GummiBiotic range for immunity, digestive health and weight management

Sirio-debuts-GummiBiotic-range-for-immunity-digestive-health-and-weight-management.jpg
© Helen Slyvinska / Getty Images

Nutraceutical contract development and manufacturing organization (CDMO) Sirio Pharma has launched a new GummiBiotic range to support a range of health benefits.

The company is using CPHI Milan to showcase the new range, which features three pectin-based products: GummiBiotics Defense, GummiBiotics IBS Ease and GummiBiotics Lean. The products are formulated with ingredients like EpiCor postbiotic and DE111 probiotic.

“At Sirio we are very proud of our R&D capabilities, where we continue to invest a significant portion of our earnings: Our technical and formulation teams account for 13% of our total employee base, something unique for a CDMO,” said Sara Lesina, general manager of Sirio Europe & Americas.

“We are constantly working with our customers and our experts to not just follow the trends but make first-in-class new products that will drive sales in new areas—and each one of these concepts is a true first for nutraceutical brands. So, we are incredibly excited to launch the new GummiBiotics range as it continues building on our partnerships with some of the best ingredient suppliers and it combines the benefits of science-backed biotics with gummies that are truly delicious.”

A booming market

The biotic supplement segment already accounts for a quarter of all supplements sold, said Sirio in a press release.

Probiotics are still the dominating subcategory under biotics, a spokesperson for the company told us. For the EU, the probiotic supplement market was sized at US$1.7 billion in 2023 and projected to grow at a CAGR of 7% from 2021 to 2024, according to Euromonitor 2024.

The global gummy market is also soaring, with an average of 14% CAGR since 2020. From 2020 to 2025, the European gummy market is forecast to grow over 50% from around $240 million in 2022 to nearly $385 million in 2025, the spokesperson said.

Specifics

The GummiBiotics Defense is formulated with 500 mg of EpiCor postbiotic per serving, said Sirio, with 5 mg of added zinc to support the normal function of the immune system.

GummiBiotics IBS Ease is built around ADM’s ES1 Postbiotic—which, in clinical studies, has been shown to help moderate some symptoms of IBS-D and deliver a reduction in occasional diarrhea. The gummy is further enhanced with prebiotic xylo-oligosaccharides and calcium, the company said.

The third product concept is GummiBiotics Lean, formulated with apple cider vinegar (500 mg per serving), vitamin B6 and DE111 (Bacillus subtilis) probiotic (5 billion CFU).